Literature DB >> 9639095

Validation of routine mycoplasma testing by PCR.

L H Toji, T C Lenchitz, V A Kwiatkowski, J A Sarama, R A Mulivor.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9639095     DOI： 10.1007/s11626-998-0014-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.723


× No keyword cloud information.
  9 in total

1.  Contamination of human cell cultures by pleuropneumonialike organisms.

Authors:  L B ROBINSON; R H WICHELHAUSEN
Journal:  Science       Date:  1956-12-07       Impact factor: 47.728

2.  Comparative studies to determine the efficiency of 6 methylpurine deoxyriboside to detect cell culture mycoplasmas.

Authors:  G J McGarrity; H Kotani; D Carson
Journal:  In Vitro Cell Dev Biol       Date:  1986-06

3.  Comparative studies between microbiological culture and uptake of uridine/uracil to detect mycoplasmal infection of cell cultures.

Authors:  G J McGarrity; V Vanaman; J Sarama
Journal:  Exp Cell Res       Date:  1979-06       Impact factor: 3.905

Review 4.  Advances in PCR-based detection of mycoplasmas contaminating cell cultures.

Authors:  G Rawadi; O Dussurget
Journal:  PCR Methods Appl       Date:  1995-02

Review 5.  Cytogenetic effects of mycoplasmal infection of cell cultures: a review.

Authors:  G J McGarrity; V Vanaman; J Sarama
Journal:  In Vitro       Date:  1984-01

Review 6.  A review of cell culture contaminations.

Authors:  J Fogh; N B Holmgren; P P Ludovici
Journal:  In Vitro       Date:  1971 Jul-Aug

Review 7.  DNA probes and PCR in diagnosis of mycoplasma infections.

Authors:  S Razin
Journal:  Mol Cell Probes       Date:  1994-12       Impact factor: 2.365

8.  Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines.

Authors:  A Hopert; C C Uphoff; M Wirth; H Hauser; H G Drexler
Journal:  J Immunol Methods       Date:  1993-08-26       Impact factor: 2.303

9.  Detection of cell culture mycoplasmas by a genetic probe.

Authors:  G J McGarrity; H Kotani
Journal:  Exp Cell Res       Date:  1986-03       Impact factor: 3.905
  9 in total
  7 in total

1.  Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines.

Authors:  Cord C Uphoff; Hans G Drexler
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-02       Impact factor: 2.416

2.  Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.

Authors:  Wei Guo; Shuhong Wu; Li Wang; Xiaoli Wei; Xiaoying Liu; Ji Wang; Zhimin Lu; Melinda Hollingshead; Bingliang Fang
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

3.  Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF.

Authors:  Harold Brem; Michael S Golinko; Olivera Stojadinovic; Arber Kodra; Robert F Diegelmann; Sasa Vukelic; Hyacinth Entero; Donald L Coppock; Marjana Tomic-Canic
Journal:  J Transl Med       Date:  2008-12-01       Impact factor: 5.531

4.  tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer.

Authors:  Yang Shao; Qiangling Sun; Xiaomin Liu; Ping Wang; Renqi Wu; Zhongliang Ma
Journal:  Chem Biol Drug Des       Date:  2017-05-22       Impact factor: 2.817

5.  The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.

Authors:  Chiara Avellini; Caterina Licini; Fabiola Olivieri; Daniela Marzioni; Raffaella Lazzarini; Rosaria Gesuita; Emanuela Guerra; Giovanni Tossetta; Clara Castellucci; Stefano Raffaele Giannubilo; Antonio Procopio; Saverio Alberti; Roberta Mazzucchelli
Journal:  Oncotarget       Date:  2017-04-25

6.  NLRP6, decreased in gastric cancer, suppresses tumorigenicity of gastric cancer cells.

Authors:  Qingqing Wang; Chunmei Wang; Jinlian Chen
Journal:  Cancer Manag Res       Date:  2018-11-27       Impact factor: 3.989

7.  Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway.

Authors:  Hao-Jie Zhang; Jing Tao; Lu Sheng; Xin Hu; Rui-Ming Rong; Ming Xu; Tong-Yu Zhu
Journal:  Onco Targets Ther       Date:  2016-03-29       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.